Substantial progress has been made since 1979 when the Canadian Task Force on the Periodic
Health Examination set about generating ‘statements of evidence’ for ranking the validity
of evidence about the effectiveness of preventative measures[14]And, although their goal was to provide a way of rating the strength and quality of studies
and link these to ‘grades of recommendations’, these ratings were based to a large extent
on the type of study design with the randomised controlled trial as the highest level.
Significantly, these grades of recommendation did not consider uncertainty around the
results nor did they incorporate explicit judgements, such as for example the weighting of
trade-offs between harms and benefits, and how these might correlate with the strength of
recommendations.
Clinical practice guidelines
Clinical guidelines have been defined as, “systematically developed statements designed
to help practitioners and patients decide on appropriate healthcare for specific
clinical conditions and circumstances”[7].The process of guideline development should be transparent, reproducible and robust and
aim to provide clinicians and other health care decision makers with comprehensive,
critical and well balanced information on the benefits and limitations of a range of
diagnostic and therapeutic interventions[2,13].The Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working
Group was established in 2000 and since that time has sought to develop a
“common, sensible and transparent approach to grading quality of evidence and
strength of recommendations”[9]. The process of development began with a review of existing grading
systems and, to ensure transparency and accountability has involved continuous input
from researchers, health professionals and methodologists.International acceptance of the GRADE system is increasing steadily and now includes a
wide range of professional bodies, medical journals and healthcare regulatory
authorities. Although clinical dentistry has been a little slower than clinical medicine
in moving towards a wider acceptance of GRADE, a number of publishers of dental
guidelines and related organizations such as for example NICE, AHRQ and BMJ Clinical
Evidence have already adopted and are using the GRADE system. The World Workshop of Oral
Medicine Committee recently used GRADE in the development of one of their guidelines for
the management of oral submucous fibrosis[12].One of the reasons suggested for the relative absence of any grading of the quality of
evidence and strengths of recommendations in clinical dentistry, was the comparative
absence of high quality evidence for the effectiveness of many dental
interventions[4]. However this
situation is hardly unique to dentistry and is in fact not uncommon in many other
disciplines of health care. Undoubtedly the pace of change and general acceptance of the
use of evidence in clinical decision-making has been somewhat slower in dentistry than
in medicine but perhaps some reassurance can be taken from the fact that
“evidence-based medicine is so far down the track it has created a powerful
vacuum, pulling evidence-based dentistry right along with it”[3].
The GRADE approach
Step number one of the process involves the formulating of important clinical questions
that address the problems and questions that dental clinicians and their patients face
in everyday practice. Key elements in the approach are clarity in defining of the
population, the treatment strategies including all alternative management strategies, in
addition to identifying all of the outcomes which are of importance to
patients[11]. Defining how broad
or narrow the question should be can be quite challenging e.g. a broader question might
compare resorbable plating systems with titanium ones for fixation after mandibular
fractures or osteotomies[1] versus a
more narrowly focused topic covering fixation of parts of the facial skeleton in
elective orthognathic surgery[5].The relative importance of each individual outcome needs to be defined by the guideline
group and in doing so it is essential that not only are clinicians involved but that
they also take patient preferences and values into consideration when rating the
importance of these outcomes. The GRADE approach then requires that all of these
important outcomes are categorised as either; critical for making a recommendation;
important but not critical; or not important from the patient’s perspective. So for
example self-assessment of oral halitosis is of far more importance as an outcome
measure to a patient as compared to a clinician-based assessment with a halimeter or via
gas chromatography[6].The most appropriate way of addressing any clinical question is through a systematic
review of the relevant evidence. The guideline group may be able to identify an existing
high quality up to date systematic review or if there is a gap in the evidence may
suggest that a review should be conducted. The GRADE working group recommends that the
resulting systematic review should be summarized in a specific structured format to
demonstrate transparently the best estimates of the benefit or adverse consequences of
the health interventions being addressed in the clinical question and this should
include the extent of our confidence in these estimates[10].
Grading the quality of evidence
The GRADE system recommends five categories that can be used in defining our confidence
in the estimate of evidence to make the grading of the evidence more transparent for its
users.Study limitations: design and implementation of available studies which are
suggestive of a high likelihood of risk of bias;Inconsistency of results: unexplained heterogeneity in the results;Indirectness of evidence: indirect population, intervention, control or
outcomes;Imprecision of results: wide confidence intervals;Reporting bias: failure to report studies that show no effect (publication bias),
outcomes that were harmful or for which no effect was observed (selective outcome
reporting).These factors can be used to guide categorizing of the evidence as ‘High Quality’ i.e.
situations in which the current evidence base leads us to the assumption that it is
unlikely that further research would change our confidence in the estimate of effect.
‘Moderate Quality’, when we can assume that further research may well change the
estimate of effect and our confidence in it. ‘Low Quality’, when we consider that it is
very likely that further research would change our estimate of effect or our confidence
in it. ‘Very Low Quality’, the current evidence leads us to be very uncertain in any
estimate of effect.
Strength of recommendation
Quality of evidence is one of the major factors in defining the strength of clinical
recommendations. Guideline developers not only need to consider the quality of evidence
but also the balance between the desirable and undesirable effects of the intervention
for the patient. In order to further increase transparency, the factors that affect the
strength of evidence have been categorized into four groups: the quality of the
evidence; any uncertainty about the balance between desirable and undesirable effects;
uncertainty or variability in the values and preferences and resource
utilisation[10]. So for example,
implant dentistry might not represent a feasible intervention in situations where
resources are limited, as indeed the use of atraumatic restorative treatment (ART) may
be a suitable alternative to the use of amalgam as a restorative material in similar
resource-poor settings[8].There are currently a very limited number of dental clinical guidelines that have
explicitly adopted the GRADE approach. We recommend that guideline groups now consider
adopting GRADE which will ensure better transparency and accountability in the process
and that the end product is not only evidence-based but also takes in to account patient
relevant outcomes.We would like to take this opportunity to encourage our dental colleagues who are in the
process of developing clinical guideline to join the GRADE Working Group so that they
can share information and participate in further methodological development in this
field.The GRADE Working Group can be accessed through their website www.gradeworkinggroup.org.The Working Group has published a series of articles which can help clinicians,
methodologists and guideline groups to get a better understanding of the GRADE approach,
these are available at http://www.gradeworkinggroup.org/publications/index.htm
Authors: Gordon H Guyatt; Andrew D Oxman; Regina Kunz; David Atkins; Jan Brozek; Gunn Vist; Philip Alderson; Paul Glasziou; Yngve Falck-Ytter; Holger J Schünemann Journal: J Clin Epidemiol Date: 2010-12-30 Impact factor: 6.437
Authors: J L Brozek; E A Akl; P Alonso-Coello; D Lang; R Jaeschke; J W Williams; B Phillips; M Lelgemann; A Lethaby; J Bousquet; G H Guyatt; H J Schünemann Journal: Allergy Date: 2009-05 Impact factor: 13.146
Authors: Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann Journal: BMJ Date: 2008-04-26
Authors: A R Kerr; S Warnakulasuriya; A J Mighell; T Dietrich; M Nasser; J Rimal; A Jalil; M M Bornstein; T Nagao; F Fortune; V H Hazarey; P A Reichart; S Silverman; N W Johnson Journal: Oral Dis Date: 2011-04 Impact factor: 3.511